United States Sepsis Diagnostic Market Growth & Trends 2025 | Major Players - Thermo Fisher Scientific Inc., Bruker Corporation, Merck Millipore

"The Global Sepsis Diagnostics Market reached US$ 710.13 million in 2023 and is expected to reach US$ 1,435.24 million by 2031, growing at a CAGR of 9.5% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/sepsis-diagnostic-market?sp

United States: Recent Industry Developments

✅ In September 2025, Abbott Laboratories launched rapid sepsis diagnostic kits for hospitals, emphasizing faster pathogen detection and improved patient outcomes. Early adoption shows reduced mortality and quicker treatment initiation.

✅ In August 2025, Roche Diagnostics expanded its sepsis biomarker testing portfolio, focusing on early detection and precision therapy guidance. Initial deployments highlight higher diagnostic accuracy and improved clinical decision-making.

✅ In July 2025, bioMérieux introduced automated sepsis identification systems for intensive care units, targeting reduced lab turnaround times and enhanced patient monitoring. Early trials report improved workflow efficiency and faster intervention.

✅ In June 2025, Thermo Fisher Scientific launched next-generation molecular assays for sepsis detection, emphasizing sensitivity and rapid results. Pilot programs demonstrate improved clinical outcomes and reduced hospital stays.
Japan: Recent Industry Developments

✅ In September 2025, Sysmex Corporation launched rapid sepsis diagnostic tests for hospitals, emphasizing early pathogen detection and improved patient care. Early adoption shows faster treatment initiation and reduced complications.

✅ In August 2025, Toshiba Medical Systems expanded sepsis biomarker testing solutions, targeting accurate and timely diagnostics for critical care units. Initial deployments highlight enhanced clinical decision support and efficiency.

✅ In July 2025, Fujirebio introduced automated sepsis monitoring platforms for intensive care, focusing on rapid detection and treatment guidance. Early trials report improved patient outcomes and workflow efficiency.

✅ In June 2025, Daiichi Sankyo launched molecular diagnostic kits for sepsis, emphasizing precision and faster results. Pilot programs demonstrate higher diagnostic accuracy and better clinical management.

Sepsis Diagnostic Market: Drivers

The sepsis diagnostics market is witnessing significant growth due to rising prevalence of sepsis, growing awareness about early detection, and the critical need for rapid, accurate diagnosis to reduce mortality rates. Advanced diagnostic technologies, including biomarker-based assays, molecular diagnostics, and point-of-care testing, enable timely identification of sepsis and guide targeted treatment strategies. Technological advancements in immunoassays, microfluidics, and high-sensitivity detection methods are improving accuracy, speed, and reliability of sepsis diagnostics. Increasing investments by healthcare providers, research institutions, and diagnostic companies are driving innovation in next-generation testing solutions. Growing focus on hospital-acquired infections, patient safety, and clinical outcome improvement is further fueling market adoption.

Integration of sepsis diagnostics with digital health platforms, electronic medical records, and AI-driven analytics is enhancing early detection, predictive monitoring, and decision-making in critical care settings. Collaborations between diagnostic firms, hospitals, and biotechnology companies are fostering the development of rapid, high-throughput, and cost-effective testing solutions. Expansion of intensive care units, emergency care facilities, and point-of-care testing capabilities is creating additional market opportunities. Regulatory approvals, clinical guidelines, and hospital protocols are facilitating broader adoption of sepsis diagnostic tools. Overall, technological innovation, rising sepsis prevalence, and the emphasis on early intervention are driving sustained growth in the global sepsis diagnostics market.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/sepsis-diagnostic-market?sp

Sepsis Diagnostic Market: Major Players

Thermo Fisher Scientific Inc., Bruker Corporation, Merck Millipore, Siemens Healthineers, Becton, Dickinson, and Company, Hoffmann-LA Roche Ltd, T2 Biosystems, Inc., Response Biomedical Corp., BioMérieux SA, and Immunexpress Inc. among others.

Segment Covered in the Sepsis Diagnostic Market:

By Product: Instruments, Software, Blood Culture Media, Assays & Reagents, Others

By Technology: Flow Cytometry, Microbiology, Biomarkers, Molecular Diagnostics, Microfluidics, Others

By Diagnostic Method: Automated Diagnostics, Conventional Diagnostics

By Pathogen: Fungal Sepsis, Bacterial Sepsis, Other Pathogens

By End-User: Hospitals, Pathology & Reference Laboratories, Others

Research Process:

Both primary and secondary data sources have been used in the Sepsis Diagnostic Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Sepsis Diagnostic Market Research Industry:

➠ Who leads the Sepsis Diagnostic industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Sepsis Diagnostic market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Sepsis Diagnostic market growth?
➠ What are the dominant sales and distribution strategies in the Sepsis Diagnostic industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=sepsis-diagnostic-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.